These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31692299)

  • 1. YAP1 promotes multidrug resistance of small cell lung cancer by CD74-related signaling pathways.
    Song Y; Sun Y; Lei Y; Yang K; Tang R
    Cancer Med; 2020 Jan; 9(1):259-268. PubMed ID: 31692299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance].
    Yang L; Hu H; Deng Y; Bai Y
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway.
    Tang R; Lei Y; Hu B; Yang J; Fang S; Wang Q; Li M; Guo L
    Br J Cancer; 2016 Jul; 115(2):243-51. PubMed ID: 27336605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of YAP1 defines neuroendocrine differentiation of lung tumors.
    Ito T; Matsubara D; Tanaka I; Makiya K; Tanei ZI; Kumagai Y; Shiu SJ; Nakaoka HJ; Ishikawa S; Isagawa T; Morikawa T; Shinozaki-Ushiku A; Goto Y; Nakano T; Tsuchiya T; Tsubochi H; Komura D; Aburatani H; Dobashi Y; Nakajima J; Endo S; Fukayama M; Sekido Y; Niki T; Murakami Y
    Cancer Sci; 2016 Oct; 107(10):1527-1538. PubMed ID: 27418196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
    Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
    Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UHRF1 plays an oncogenic role in small cell lung cancer.
    Hou J; Li W; Zhang S; Tan D; Lv K; Zhu Y; Hou Y; Guo H; Jiang L
    Mol Carcinog; 2023 Mar; 62(3):385-397. PubMed ID: 36537722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
    Ng J; Cai L; Girard L; Prall OWJ; Rajan N; Khoo C; Batrouney A; Byrne DJ; Boyd DK; Kersbergen AJ; Christie M; Minna JD; Burr ML; Sutherland KD
    Clin Cancer Res; 2024 May; 30(9):1846-1858. PubMed ID: 38180245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition.
    Li D; Tong Q; Lian Y; Chen Z; Zhu Y; Huang W; Wen Y; Wang Q; Liang S; Li M; Zheng J; Liu Z; Liu H; Guo L
    Cancer Res Treat; 2021 Oct; 53(4):1042-1056. PubMed ID: 33705625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
    Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F
    Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc finger protein 367 exerts a cancer-promoting role in small cell lung cancer by influencing the CIT/LATS2/YAP signaling cascade.
    Kong R; Ma Y; Li W; Xu Z; Gong S; Liu A; Cheng C; Zhang X; Qin J; Li S; Feng J; Jiang J
    Toxicol Appl Pharmacol; 2024 Aug; 489():117005. PubMed ID: 38880190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
    Ma L; Li P; Wang R; Nan Y; Liu X; Jin F
    Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells.
    Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G
    Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.